Literature DB >> 1406701

Activation of insulin-like growth factor II expression during skeletal muscle regeneration in the rat: correlation with myotube formation.

A Levinovitz1, E Jennische, A Oldfors, D Edwall, G Norstedt.   

Abstract

Insulin-like growth factors (IGFs) are important stimulators of proliferation and differentiation of cultured myoblasts. It has previously been shown that IGF-I is induced during muscle regeneration in rodents, however, little is known about the expression of IGF-II. Therefore, two in vivo models were used to analyze IGF-II mRNA expression during skeletal muscle regeneration in the rat: injection of the snake venom notexin and induction of ischemia. During the regeneration process the levels of both IGF-I and IGF-II mRNA were transiently induced, as analyzed by solution hybridization. Both IGF-I-like immunoreactivity and IGF-II-like immunoreactivity were found to be present during muscle regeneration. In a time course study, induction of IGF-II was preceded by IGF-I, both at the mRNA and protein levels. Using alpha- and beta-actin as markers for different stages of skeletal muscle differentiation, together with the immunohistochemistry data, it is concluded that the expression of IGF-I and IGF-II occurs at different differentiation stages, and that IGF-II appears concomitant to the formation of myotubes. These results suggest that each IGF has a distinct role during the differentiation of muscle cells.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1406701     DOI: 10.1210/mend.6.8.1406701

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  17 in total

1.  Dual control of muscle cell survival by distinct growth factor-regulated signaling pathways.

Authors:  M A Lawlor; X Feng; D R Everding; K Sieger; C E Stewart; P Rotwein
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

2.  Insulin-like growth factor-mediated muscle cell survival: central roles for Akt and cyclin-dependent kinase inhibitor p21.

Authors:  M A Lawlor; P Rotwein
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

3.  VEGF protein in human ischemic skeletal muscle.

Authors:  Martin Flück; Thomas Gustafsson
Journal:  Am J Pathol       Date:  2003-12       Impact factor: 4.307

4.  Sequence of IGF-I, IGF-II, and HGF expression in regenerating skeletal muscle.

Authors:  Shinichiro Hayashi; Hisashi Aso; Kouichi Watanabe; Hidetoshi Nara; Michael T Rose; Shyuichi Ohwada; Takahiro Yamaguchi
Journal:  Histochem Cell Biol       Date:  2004-10-05       Impact factor: 4.304

5.  Changes in some troponin and insulin-like growth factor messenger ribonucleic acids in regenerating and denervated skeletal muscles.

Authors:  K Krishan; G K Dhoot
Journal:  J Muscle Res Cell Motil       Date:  1996-10       Impact factor: 2.698

Review 6.  Cytokines in exertion-induced skeletal muscle injury.

Authors:  J G Cannon; B A St Pierre
Journal:  Mol Cell Biochem       Date:  1998-02       Impact factor: 3.396

Review 7.  Skeletal muscle hypertrophy and regeneration: interplay between the myogenic regulatory factors (MRFs) and insulin-like growth factors (IGFs) pathways.

Authors:  Nadège Zanou; Philippe Gailly
Journal:  Cell Mol Life Sci       Date:  2013-04-04       Impact factor: 9.261

8.  Impact of treadmill locomotor training on skeletal muscle IGF1 and myogenic regulatory factors in spinal cord injured rats.

Authors:  Min Liu; Jennifer E Stevens-Lapsley; Arun Jayaraman; Fan Ye; Christine Conover; Glenn A Walter; Prodip Bose; Floyd J Thompson; Stephen E Borst; Krista Vandenborne
Journal:  Eur J Appl Physiol       Date:  2010-03-07       Impact factor: 3.078

9.  Insulin-like growth factor (IGF-I) induces myotube hypertrophy associated with an increase in anaerobic glycolysis in a clonal skeletal-muscle cell model.

Authors:  C Semsarian; P Sutrave; D R Richmond; R M Graham
Journal:  Biochem J       Date:  1999-04-15       Impact factor: 3.857

10.  Insulin-like growth factor-II regulates maternal hemodynamic adaptation to pregnancy in rats.

Authors:  Tim Van Mieghem; Rita van Bree; Erik Van Herck; Jan Deprest; Johan Verhaeghe
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-09-23       Impact factor: 3.619

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.